nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—PDE6H—forebrain—attention deficit hyperactivity disorder	0.0884	0.119	CbGeAlD
Sildenafil—PDE6H—nervous system—attention deficit hyperactivity disorder	0.048	0.0645	CbGeAlD
Sildenafil—PDE6H—central nervous system—attention deficit hyperactivity disorder	0.0462	0.0621	CbGeAlD
Sildenafil—ADORA2A—forebrain—attention deficit hyperactivity disorder	0.0369	0.0496	CbGeAlD
Sildenafil—PDE6H—brain—attention deficit hyperactivity disorder	0.0367	0.0493	CbGeAlD
Sildenafil—PDE5A—forebrain—attention deficit hyperactivity disorder	0.0336	0.0452	CbGeAlD
Sildenafil—ADORA2A—cardiovascular system—attention deficit hyperactivity disorder	0.0312	0.042	CbGeAlD
Sildenafil—PDE5A—cardiovascular system—attention deficit hyperactivity disorder	0.0284	0.0382	CbGeAlD
Sildenafil—ABCC4—forebrain—attention deficit hyperactivity disorder	0.0213	0.0286	CbGeAlD
Sildenafil—ABCC5—midbrain—attention deficit hyperactivity disorder	0.0203	0.0273	CbGeAlD
Sildenafil—ADORA2A—nervous system—attention deficit hyperactivity disorder	0.02	0.0269	CbGeAlD
Sildenafil—ADORA2A—central nervous system—attention deficit hyperactivity disorder	0.0193	0.0259	CbGeAlD
Sildenafil—ADORA2A—cerebellum—attention deficit hyperactivity disorder	0.0189	0.0253	CbGeAlD
Sildenafil—PDE5A—nervous system—attention deficit hyperactivity disorder	0.0183	0.0245	CbGeAlD
Sildenafil—PDE5A—central nervous system—attention deficit hyperactivity disorder	0.0176	0.0236	CbGeAlD
Sildenafil—PDE5A—cerebellum—attention deficit hyperactivity disorder	0.0172	0.0231	CbGeAlD
Sildenafil—ABCC10—midbrain—attention deficit hyperactivity disorder	0.017	0.0228	CbGeAlD
Sildenafil—ABCC5—cerebellum—attention deficit hyperactivity disorder	0.0157	0.0211	CbGeAlD
Sildenafil—ADORA2A—brain—attention deficit hyperactivity disorder	0.0153	0.0206	CbGeAlD
Sildenafil—PDE5A—brain—attention deficit hyperactivity disorder	0.014	0.0188	CbGeAlD
Sildenafil—ABCC10—cerebellum—attention deficit hyperactivity disorder	0.0131	0.0176	CbGeAlD
Sildenafil—ABCC5—brain—attention deficit hyperactivity disorder	0.0128	0.0172	CbGeAlD
Sildenafil—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0116	0.0156	CbGeAlD
Sildenafil—ABCC4—nervous system—attention deficit hyperactivity disorder	0.0116	0.0156	CbGeAlD
Sildenafil—ABCC4—central nervous system—attention deficit hyperactivity disorder	0.0111	0.015	CbGeAlD
Sildenafil—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.011	0.0148	CbGeAlD
Sildenafil—ABCC10—brain—attention deficit hyperactivity disorder	0.0107	0.0143	CbGeAlD
Sildenafil—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0103	0.0139	CbGeAlD
Sildenafil—ABCC4—brain—attention deficit hyperactivity disorder	0.00884	0.0119	CbGeAlD
Sildenafil—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00775	0.0104	CbGeAlD
Sildenafil—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00747	0.01	CbGeAlD
Sildenafil—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00707	0.0095	CbGeAlD
Sildenafil—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00681	0.00915	CbGeAlD
Sildenafil—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00665	0.00894	CbGeAlD
Sildenafil—CYP1A1—brain—attention deficit hyperactivity disorder	0.00593	0.00797	CbGeAlD
Sildenafil—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00569	0.00765	CbGeAlD
Sildenafil—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.0056	0.00753	CbGeAlD
Sildenafil—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00548	0.00736	CbGeAlD
Sildenafil—CYP2E1—brain—attention deficit hyperactivity disorder	0.00541	0.00727	CbGeAlD
Sildenafil—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00539	0.00725	CbGeAlD
Sildenafil—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00527	0.00708	CbGeAlD
Sildenafil—CYP2D6—brain—attention deficit hyperactivity disorder	0.00428	0.00575	CbGeAlD
Sildenafil—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00256	0.00999	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00253	0.00989	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00251	0.00981	CbGpPWpGaD
Sildenafil—ADORA2A—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00251	0.0098	CbGpPWpGaD
Sildenafil—ABCC5—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00248	0.0097	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00248	0.00969	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00246	0.00962	CbGpPWpGaD
Sildenafil—ADORA2A—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.0023	0.00897	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00229	0.00893	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00224	0.00875	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00218	0.00852	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00217	0.00847	CbGpPWpGaD
Sildenafil—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00215	0.0084	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00213	0.00833	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00212	0.0083	CbGpPWpGaD
Sildenafil—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00198	0.00773	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00197	0.0077	CbGpPWpGaD
Sildenafil—PDE6G—Disease—STUB1—attention deficit hyperactivity disorder	0.00195	0.00761	CbGpPWpGaD
Sildenafil—ABCC4—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00193	0.00754	CbGpPWpGaD
Sildenafil—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00191	0.00745	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00177	0.00692	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00175	0.00683	CbGpPWpGaD
Sildenafil—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00174	0.00681	CbGpPWpGaD
Sildenafil—ABCC4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00172	0.00672	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00172	0.00671	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00171	0.00666	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00171	0.00666	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00165	0.00645	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00165	0.00645	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00162	0.00632	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.0016	0.00626	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00158	0.00619	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00151	0.00591	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00151	0.0059	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0015	0.00587	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00149	0.00584	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00147	0.00575	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0014	0.00546	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00139	0.00544	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00137	0.00533	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00135	0.00528	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00133	0.00519	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00132	0.00515	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00131	0.00513	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00129	0.00506	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00129	0.00503	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00126	0.00494	CbGpPWpGaD
Sildenafil—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00126	0.00494	CbGpPWpGaD
Sildenafil—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00126	0.00493	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00122	0.00478	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0012	0.00467	CbGpPWpGaD
Sildenafil—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00119	0.00465	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.00458	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00116	0.00453	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00115	0.00449	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00114	0.00445	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00113	0.0044	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00113	0.00439	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00112	0.00438	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STUB1—attention deficit hyperactivity disorder	0.00105	0.00411	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00105	0.00409	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00098	0.00383	CbGpPWpGaD
Sildenafil—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000975	0.00381	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000933	0.00365	CbGpPWpGaD
Sildenafil—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000933	0.00365	CbGpPWpGaD
Sildenafil—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000927	0.00362	CbGpPWpGaD
Sildenafil—PDE6G—Disease—SNAP25—attention deficit hyperactivity disorder	0.000924	0.00361	CbGpPWpGaD
Sildenafil—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00092	0.0036	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000914	0.00357	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000911	0.00356	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000902	0.00352	CbGpPWpGaD
Sildenafil—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000897	0.0035	CbGpPWpGaD
Sildenafil—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000889	0.00347	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000883	0.00345	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000868	0.00339	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000857	0.00335	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000857	0.00335	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000847	0.00331	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00083	0.00324	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000798	0.00312	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000796	0.00311	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000795	0.00311	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000785	0.00307	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000785	0.00307	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000757	0.00296	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000746	0.00292	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000734	0.00287	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000696	0.00272	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00068	0.00266	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000676	0.00264	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000675	0.00263	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000671	0.00262	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00067	0.00262	CbGpPWpGaD
Sildenafil—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000667	0.0026	CbGpPWpGaD
Sildenafil—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000665	0.0026	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000647	0.00253	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000637	0.00249	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000634	0.00248	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000633	0.00247	CbGpPWpGaD
Sildenafil—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000629	0.00246	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000627	0.00245	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000616	0.00241	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000608	0.00238	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000605	0.00236	CbGpPWpGaD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000586	0.00229	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000583	0.00228	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000576	0.00225	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000567	0.00221	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000559	0.00218	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000554	0.00217	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000554	0.00216	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000551	0.00215	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000523	0.00204	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000523	0.00204	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000522	0.00204	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000518	0.00202	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000515	0.00201	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000514	0.00201	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000514	0.00201	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000503	0.00196	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000501	0.00196	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SNAP25—attention deficit hyperactivity disorder	0.000499	0.00195	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000499	0.00195	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00049	0.00192	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00049	0.00191	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000484	0.00189	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000481	0.00188	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00048	0.00187	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000478	0.00187	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000476	0.00186	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000476	0.00186	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000473	0.00185	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000472	0.00184	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000469	0.00183	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000468	0.00183	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000453	0.00177	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000451	0.00176	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000445	0.00174	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00044	0.00172	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000418	0.00163	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00041	0.0016	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000398	0.00155	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000397	0.00155	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000391	0.00153	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000382	0.00149	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000382	0.00149	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00034	0.00133	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000317	0.00124	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000316	0.00123	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000315	0.00123	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000314	0.00122	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000311	0.00122	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000309	0.00121	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EP300—attention deficit hyperactivity disorder	0.0003	0.00117	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000297	0.00116	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000287	0.00112	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.00108	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000276	0.00108	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.00108	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000268	0.00105	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000264	0.00103	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000263	0.00103	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000263	0.00103	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000263	0.00103	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000261	0.00102	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00026	0.00101	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000259	0.00101	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000242	0.000945	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000241	0.000941	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000232	0.000907	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000213	0.000833	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000211	0.000823	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00021	0.000822	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.0002	0.000783	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000196	0.000766	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000194	0.00076	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000191	0.000745	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000191	0.000745	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00019	0.000744	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00019	0.000744	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000188	0.000733	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000187	0.000732	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00018	0.000703	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00018	0.000703	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000177	0.000691	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000175	0.000682	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000174	0.00068	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000169	0.000662	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000165	0.000643	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EP300—attention deficit hyperactivity disorder	0.000162	0.000634	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.00016	0.000623	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000158	0.000619	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000153	0.000596	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000152	0.000595	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000147	0.000575	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000147	0.000575	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000567	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000566	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000145	0.000566	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000144	0.000562	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000137	0.000535	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000136	0.000531	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000135	0.000529	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000135	0.000529	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000135	0.000526	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000134	0.000524	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000134	0.000524	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000133	0.00052	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000132	0.000516	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.000501	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000124	0.000484	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000123	0.00048	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000118	0.00046	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000116	0.000452	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000115	0.000451	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000115	0.000448	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000115	0.000447	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.000438	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000109	0.000426	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000108	0.000423	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000108	0.000423	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000107	0.000419	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000105	0.00041	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000402	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.000399	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.98e-05	0.000351	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	8.92e-05	0.000348	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	8.86e-05	0.000346	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.85e-05	0.000346	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	8.85e-05	0.000346	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	8.71e-05	0.00034	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.59e-05	0.000335	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	8.2e-05	0.00032	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	8.15e-05	0.000318	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	8.13e-05	0.000318	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.1e-05	0.000316	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	8.07e-05	0.000315	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.83e-05	0.000306	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.08e-05	0.000276	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	6.84e-05	0.000267	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.74e-05	0.000263	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	5.36e-05	0.000209	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	5.33e-05	0.000208	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	4.96e-05	0.000194	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	4.95e-05	0.000193	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.67e-05	0.000183	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	3.82e-05	0.000149	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.52e-05	0.000137	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.49e-05	0.000136	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.3e-05	8.98e-05	CbGpPWpGaD
